__NUXT_JSONP__("/drugs/Galiximab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"357613-77-5",chebiId:b,chemicalFormula:b,definition:"A chimeric IgG1 monoclonal antibody directed against CD80, the natural ligand for the T-cell antigen CD28 which mediates T-cell and B-cell adhesion. Galiximab binds to CD80 expressed on the cell surfaces of follicular lymphomas, resulting in antibody-dependent cell-mediated cytotoxicity (ADCC). CD80 is expressed on activated B-cells and gamma-interferon-stimulated monocytes and is often expressed at low levels on the surfaces of follicular lymphoma cells and other lymphoid malignancies.",fdaUniiCode:"S9OX9692ZB",identifier:"C26447",preferredName:a,semanticType:"Immunologic Factor",subclassOf:["C20401"],synonyms:["GALIXIMAB",a,"IDEC-114","anti-B7-1","anti-CD80 Antibody","galiximab"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FGaliximab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Galiximab","","2021-10-30T13:37:58.923Z")));